News
04.04.2025
Kerstin Westritschnig joins International Vaccine Institute as Head of its Austria office
02.04.2025
University Vienna: New antibiotic for multidrug resistant superbug, that causes gonorrhoea
01.04.2025
Catherine Emond übernimmt Führungsrolle als Country President bei Novartis Österreich
01.04.2025
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
31.03.2025
Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA
28.03.2025
European Commission releases open-source HealthData@EU Central Platform — a key milestone for the European Health Data Space